AtheroNova Inc

(AHRO)

By |

Profile

AtheroNova Inc is a clinical stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits. The company's focus on compounds to reduce or eliminate atherosclerotic plaque deposits addresses the most lucrative segments of the multi-billion-dollar prescription drug market: cardiovascular disease and stroke prevention.

Contact Information

Website: www.atheronova.com
Main Phone: +1 949 476-1100
Address: 2301 Dupont Drive
Address 2: Suite 525
State: CA
City / Town: Irvine
Country: USA
Postal Code: 92612

Issuer Information

Exchange: OTO
CEO: Thomas W Gardner
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 8,809,139.00 EPS (TTM) -2.55 PE Ratio N/A Exchange OTCPK